JPRN-UMIN000047182
Completed
未知
Performance verification test of a software medical device with artificial intelligence to detect signs of paroxysmal atrial fibrillation - Performance verification test of a software medical device with artificial intelligence to detect signs of paroxysmal atrial fibrillation
IUHW0 sites45 target enrollmentMarch 16, 2022
Conditionsparoxysmal atrial fibrillation
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- paroxysmal atrial fibrillation
- Sponsor
- IUHW
- Enrollment
- 45
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Paroxysmal atrial fibrillation group 1\.Persons diagnosed with persistent or permanent atrial fibrillation 2\.Persons undergoing treatment(catheter ablation, open heart surgery, pacemaker implantation, percutaneous atrial septal defect closure) Control group 1\.Persons who have a history of diagnosis of paroxysmal atrial fibrillation, persistent atrial fibrillation, or permanent atrial fibrillation 2\.Persons undergoing treatment(catheter ablation, open heart surgery, pacemaker implantation, percutaneous atrial septal defect closure)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Performance verification test of a software medical device with artificial intelligence to detect signs of paroxysmal atrial fibrillatioparoxysmal atrial fibrillationAtrial FibrillationD001281JPRN-jRCT2032220573Tamura Yuichi45
Active, not recruiting
Phase 1
Validation of a test system for development of medications for alcoholismEUCTR2015-002831-16-DETechnische Universität Dresden
Not yet recruiting
Not Applicable
A performance evaluation study for the testing of DNA extracted from either tumor tissue biopsy samples or plasma, using the therascreen® EGFR Plus RGQ PCR Kit, from subjects with Non-Small Cell Lung Cancer, being screened for inclusion in Taiho Oncology, Inc*s Clinical Trial (Protocol No. 10073010).Lung CancerNon Small Cell Lung Cancer10038666NL-OMON56744QIAGE15
Recruiting
Not Applicable
A study to determine the ability of a blood test for B-type Natriuretic Peptide signal peptide (BNP-SP) to act as an early indicator in Acute Coronary Syndrome (ACS)).ACTRN12609000057280Health Research Council of New Zealand2,000
Recruiting
Not Applicable
Testing of a new test system for diagnosis and therapy planning of severe blistering autoimmune diseases of the skiL10.0L12.0Pemphigus vulgarisBullous pemphigoidDRKS00027499niversitätsklinikum der RWTH Aachen40